Autosomal dominant leukodystrophy with autonomic disease | |
---|---|
Other names | Autosomal dominant adult-onset demyelinating leukodystrophy, ADLD, Adult-onset autosomal dominant demyelinating leukodystrophy, Adult-onset autosomal dominant leukodystrophy, Leukodystrophy, demyelinating, adult-onset, autosomal dominant, Pelizaeus-Merzbacher disease, autosomal dominant or late-onset type, Multiple sclerosis-like disorder[1] |
Specialty | Medical genetics |
Symptoms | Cognitive deficits, ataxia, and dysfunctions of the autonomic system |
Complications | Walking difficulties |
Usual onset | Adulthood |
Duration | Lifelong |
Causes | Genetic mutation |
Diagnostic method | Genetic testing |
Differential diagnosis | Multiple sclerosis |
Prevention | none |
Prognosis | Bad, but quality of life can be improved with treatment |
Frequency | rare, at least 70 people on Earth have been diagnosed with the condition |
Deaths | Inevitable in patients with this condition |
Autosomal dominant leukodystrophy with autonomic disease is a rare neurological condition of genetic origin which is characterized by gradual demyelination of the central nervous system which results in various impairments, including ataxia, mild cognitive disability and autonomic dysfunction.[2][3][4] It is part of a group of disorders called "leukodystrophies".[5][6]